Skip to main content
Fig. 1 | BMC Pharmacology and Toxicology

Fig. 1

From: Dehydroxymethylepoxyquinomicin, a novel nuclear factor-κB inhibitor, prevents the development of cyclosporine A nephrotoxicity in a rat model

Fig. 1

Schematic representation of the experimental design. Rats underwent 5/6 nephrectomy 7 days after the feeding with a low-sodium diet (0.01% NaCl) began. In the CsA treatment group (15 mg/kg), CsA administration began on the day of surgery and continued daily for 28 days. If the rats were cotreated with DHMEQ (8 mg/kg), DHMEQ administration began on the same day and continued daily for 28 days

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us